Monograph

B01AB02 - Antithrombin III

Not porphyrinogenic

Rationale

Glycoprotein. Non-CYP dependent metabolism.

Chemical description

Anticagulant glycoprotein isolated from human plasma.

Similar drugs

Explore alternative drugs in similar therapeutic classes B01A / B01AB or go back.

Tradenames and packages

From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Netherlands

Antitrombine III · Antitrombine III concentraat Baxalta 500 IE, poeder en oplosmiddel voor injectie of intraveneuze infusie · ATenativ · ATenativ, poeder voor infusievloeistof 500 IE en 1000 IE

Belgium

Concentré d'Antithrombine III · Concentré d'Antithrombine III Baxalta 1 000 UI sol. inj./perf. (pdr. + solv.) i.v. flac. · Concentré d'Antithrombine III Baxalta 500 UI sol. inj./perf. (pdr. + solv.) i.v. flac.

United Kingdom

Antithrombin III · Antithrombin III 1,000unit powder and solvent for solution for infusion vials · Kybernin P · Kybernin P 1,000unit powder and solvent for solution for infusion vials · Kybernin P 500unit powder and solvent for solution for infusion vials

Denmark